The antitumor ether lipid edelfosine (ET-18-O-CH3) induces apoptosis in H-ras transformed human breast epithelial cells: by blocking ERK1/2 and p38 mitogen-activated protein kinases as potential targets.

We previously reported that a novel alkylphospholipid type antitumor agent edelfosine (ET-18-O-CH3 ; 1-O-octadecyl-2-O-methyl-glycero-3-phosphocholine) induced apoptosis in human breast epithelial cells transfected with the H-ras oncogene (MCF10A-ras) which was causally linked to cyclooxygenase-2 (COX-2) up-regulation and production of 15-deoxy-Delta 12,14-prostaglandins J2 (15d-PGJ2). ET-18-O-CH3 treatment also enhanced the production of prostaglandin E2 (PGE2), a major COX-2 product. In this study, we found that ET-18-O-CH3 treatment resulted in elevated mRNA expression of the PGE2 receptor subunit, EP2 receptor. Exogenously added PGE2 inhibited the growth of MCF10A-ras cells and induced proteolytic cleavage of caspase 3. ET-18-O-CH3 also inhibited constitutive activation of ERK1/2, p38 MAPK, and Akt/protein kinase B, which was blunted by a selective COX-2 inhibitor SC58635. In addition, ET-18-O-CH3 inhibited DNA binding activity of NF-kappa B in MCF10A-ras cells, and this was again attenuated by SC58635. Based on these findings, it is likely that ET-18-O-CH3 inactivates ERK1/2, Akt, and NF-kappaB signaling via COX-2 induction in MCF10A-ras cells, thereby inducing apoptosis of these cells.

[1]  R. Piva,et al.  Induction of Apoptosis in Estrogen-Receptor Negative Breast Cancer Cells by Natural and Synthetic Cyclopentenones : Role of the IKK / NF-κ B Pathway , 2006 .

[2]  Y. Oshika,et al.  P-glycoprotein-mediated acquired multidrug resistance of human lung cancer cells in vivo. , 1996, British Journal of Cancer.

[3]  R. Handrick,et al.  Membrane targeted anticancer drugs: potent inducers of apoptosis and putative radiosensitisers. , 2003, Current medicinal chemistry. Anti-cancer agents.

[4]  R. Mayer,et al.  Inhibitors of coenzyme A-independent transacylase induce apoptosis in human HL-60 cells. , 1996, The Journal of pharmacology and experimental therapeutics.

[5]  W. Farrar,et al.  Co‐operative functions between nuclear factors NFκB and CCAT/enhancer‐binding protein‐β (C/EBP‐β) regulate the IL‐6 promoter in autocrine human prostate cancer cells , 2004 .

[6]  J. Davaille,et al.  Antiproliferative Properties of Sphingosine 1-Phosphate in Human Hepatic Myofibroblasts , 2000, The Journal of Biological Chemistry.

[7]  O. Ishiko,et al.  Association between overexpression of cyclooxygenase-2 and suppression of apoptosis in advanced cancer of the uterine cervix after cyclic balloon-occluded arterial infusion. , 2001, Oncology reports.

[8]  Carol L. Williams,et al.  Non-small and small cell lung carcinoma cell lines exhibit cell type-specific sensitivity to edelfosine-induced cell death and different cell line-specific responses to edelfosine treatment. , 2003, International journal of oncology.

[9]  Zong-hou Shen,et al.  Modulation of the basal activity of N-acetylglucosaminyltransferase V by phosphatidylinositol-3-kinase/protein kinase B signaling pathway in human hepatocarcinoma cells , 2000, Glycoconjugate Journal.

[10]  F. Civoli,et al.  Quaternary ammonium analogs of ether lipids inhibit the activation of protein kinase C and the growth of human leukemia cell lines , 1998, Cancer Chemotherapy and Pharmacology.

[11]  E. Solary,et al.  A new class of anticancer alkylphospholipids uses lipid rafts as membrane gateways to induce apoptosis in lymphoma cells , 2007, Molecular Cancer Therapeutics.

[12]  A. Fonteh,et al.  Relationship between arachidonate--phospholipid remodeling and apoptosis. , 1996, Biochemistry.

[13]  Y. Surh,et al.  ET‐18‐O‐CH3‐induced apoptosis is causally linked to COX‐2 upregulation in H‐ras transformed human breast epithelial cells , 2005, FEBS letters.

[14]  R. Ramer,et al.  Up-Regulation of Cyclooxygenase-2 Expression Is Involved in R(+)-Methanandamide-Induced Apoptotic Death of Human Neuroglioma Cells , 2004, Molecular Pharmacology.

[15]  Y. Song,et al.  Celecoxib inhibits phorbol ester-induced expression of COX-2 and activation of AP-1 and p38 MAP kinase in mouse skin. , 2003, Carcinogenesis.

[16]  F. Cianchi,et al.  Up-regulation of cyclooxygenase 2 gene expression correlates with tumor angiogenesis in human colorectal cancer. , 2001, Gastroenterology.

[17]  O. Ishiko,et al.  Expression of apoptosis regulatory proteins in advanced cancer of the uterine cervix after cyclic balloon-occluded arterial infusion chemotherapy. , 2001, International journal of oncology.

[18]  J. Trosko,et al.  Growth suppression of a tumorigenic rat liver cell line by the anticancer agent, ET-18-O-CH3, is mediated by inhibition of cytokinesis , 2003, Cancer Chemotherapy and Pharmacology.

[19]  M. Karin.  Nuclear factor-κB in cancer development and progression , 2006, Nature.

[20]  Li Liu,et al.  Apoptosis in cerebellar granule neurons is associated with reduced interaction between CREB‐binding protein and NF‐κB , 2003, Journal of neurochemistry.

[21]  F. Mollinedo,et al.  Selective induction of apoptosis in cancer cells by the ether lipid ET-18-OCH3 (Edelfosine): molecular structure requirements, cellular uptake, and protection by Bcl-2 and Bcl-X(L). , 1997, Cancer research.

[22]  S. Grösch,et al.  Cyclooxygenase-2 (COX-2)-independent anticarcinogenic effects of selective COX-2 inhibitors. , 2006, Journal of the National Cancer Institute.

[23]  Faustino Mollinedo,et al.  Edelfosine and perifosine induce selective apoptosis in multiple myeloma by recruitment of death receptors and downstream signaling molecules into lipid rafts. , 2007, Blood.